The Vox Markets Podcast
/
Jonathan Tobin, MD of Arix Bioscience discusses one of their portfolio companies, Artios Pharma, that's announced global strategic collaboration with Merck worth $7bn
Our new player has been redesigned to fit in better wherever you embed it. Feedback is welcome on our support site.
You can still use our old player if you prefer.